ADMA logo

ADMA Biologics (ADMA) Net Income

Annual Net Income

-$28.24 M
+$37.66 M+57.15%

December 31, 2023


Summary


Performance

ADMA Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherADMAprofitabilitymetrics:

Quarterly Net Income

$35.91 M
+$3.85 M+12.00%

September 30, 2024


Summary


Performance

ADMA Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherADMAprofitabilitymetrics:

TTM Net Income

$68.13 M
+$33.34 M+95.85%

September 30, 2024


Summary


Performance

ADMA TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherADMAprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ADMA Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+57.1%0.0%0.0%
3 y3 years+62.7%0.0%0.0%
5 y5 years+57.0%0.0%0.0%

ADMA Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+60.6%at high+243.6%at high+187.0%
5 y5-yearat high+62.7%at high+243.6%at high+187.0%
alltimeall time<-9999.0%+62.7%at high+243.6%at high+187.0%

ADMA Biologics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
$35.91 M(+12.0%)
$68.13 M(+95.8%)
Jun 2024
-
$32.06 M(+80.1%)
$34.79 M(-1054.4%)
Mar 2024
-
$17.81 M(-200.9%)
-$3.65 M(-87.1%)
Dec 2023
-$28.24 M(-57.2%)
-$17.64 M(-787.9%)
-$28.24 M(+23.7%)
Sep 2023
-
$2.56 M(-140.3%)
-$22.83 M(-43.3%)
Jun 2023
-
-$6.37 M(-6.2%)
-$40.29 M(-15.5%)
Mar 2023
-
-$6.79 M(-44.5%)
-$47.69 M(-27.6%)
Dec 2022
-$65.90 M(-8.0%)
-$12.23 M(-17.9%)
-$65.90 M(-6.3%)
Sep 2022
-
-$14.90 M(+8.2%)
-$70.32 M(-3.8%)
Jun 2022
-
-$13.76 M(-45.0%)
-$73.14 M(-6.6%)
Mar 2022
-
-$25.01 M(+50.2%)
-$78.28 M(+9.3%)
Dec 2021
-$71.65 M(-5.4%)
-$16.65 M(-6.0%)
-$71.65 M(-3.7%)
Sep 2021
-
-$17.71 M(-6.3%)
-$74.41 M(+1.1%)
Jun 2021
-
-$18.91 M(+2.9%)
-$73.61 M(-1.7%)
Mar 2021
-
-$18.38 M(-5.3%)
-$74.88 M(-1.1%)
Dec 2020
-$75.75 M(+56.9%)
-$19.41 M(+14.7%)
-$75.75 M(+13.2%)
Sep 2020
-
-$16.92 M(-16.2%)
-$66.90 M(+8.9%)
Jun 2020
-
-$20.18 M(+4.8%)
-$61.42 M(+12.8%)
Mar 2020
-
-$19.25 M(+82.2%)
-$54.46 M(+12.8%)
Dec 2019
-$48.28 M(-26.6%)
-$10.56 M(-7.7%)
-$48.28 M(-13.4%)
Sep 2019
-
-$11.44 M(-13.4%)
-$55.76 M(-6.2%)
Jun 2019
-
-$13.21 M(+1.1%)
-$59.45 M(-2.5%)
Mar 2019
-
-$13.07 M(-27.6%)
-$60.99 M(-7.2%)
Dec 2018
-$65.74 M(+50.2%)
-$18.04 M(+19.2%)
-$65.74 M(+8.3%)
Sep 2018
-
-$15.14 M(+2.6%)
-$60.69 M(-0.1%)
Jun 2018
-
-$14.75 M(-17.2%)
-$60.76 M(+10.4%)
Mar 2018
-
-$17.82 M(+37.3%)
-$55.04 M(+25.8%)
Dec 2017
-$43.76 M
-$12.98 M(-14.6%)
-$43.76 M(+23.8%)
Sep 2017
-
-$15.20 M(+68.2%)
-$35.34 M(+44.4%)
Jun 2017
-
-$9.04 M(+38.2%)
-$24.46 M(+14.1%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$6.54 M(+43.4%)
-$21.44 M(+9.9%)
Dec 2016
-$19.52 M(+8.6%)
-$4.56 M(+5.3%)
-$19.52 M(-0.1%)
Sep 2016
-
-$4.33 M(-28.0%)
-$19.54 M(-3.8%)
Jun 2016
-
-$6.01 M(+30.3%)
-$20.31 M(+7.0%)
Mar 2016
-
-$4.61 M(+0.7%)
-$18.98 M(+5.6%)
Dec 2015
-$17.97 M(+6.9%)
-$4.58 M(-10.2%)
-$17.97 M(+6.0%)
Sep 2015
-
-$5.10 M(+9.0%)
-$16.95 M(+11.3%)
Jun 2015
-
-$4.68 M(+29.8%)
-$15.23 M(+4.9%)
Mar 2015
-
-$3.61 M(+1.2%)
-$14.51 M(-13.7%)
Dec 2014
-$16.81 M(+8.3%)
-$3.56 M(+5.3%)
-$16.81 M(-6.3%)
Sep 2014
-
-$3.38 M(-14.6%)
-$17.95 M(+4.0%)
Jun 2014
-
-$3.96 M(-32.9%)
-$17.26 M(-5.1%)
Mar 2014
-
-$5.90 M(+25.6%)
-$18.19 M(+17.1%)
Dec 2013
-$15.53 M(+112.7%)
-$4.70 M(+74.8%)
-$15.53 M(+18.7%)
Sep 2013
-
-$2.69 M(-45.1%)
-$13.08 M(-4.1%)
Jun 2013
-
-$4.90 M(+51.0%)
-$13.63 M(+37.1%)
Mar 2013
-
-$3.24 M(+44.0%)
-$9.95 M(+36.2%)
Dec 2012
-$7.30 M(>+9900.0%)
-$2.25 M(-30.6%)
-$7.30 M(+44.3%)
Sep 2012
-
-$3.25 M(+169.0%)
-$5.06 M(+178.3%)
Jun 2012
-
-$1.21 M(+102.0%)
-$1.82 M(+192.0%)
Mar 2012
-
-$597.30 K(+7096.4%)
-$622.50 K(+1968.1%)
Dec 2011
-
-$8300.00(+59.6%)
-$30.10 K(+11.5%)
Sep 2011
-
-$5200.00(-55.6%)
-$27.00 K(+2.3%)
Jun 2011
-$26.50 K(+29.3%)
-$11.70 K(+138.8%)
-$26.40 K(+18.4%)
Mar 2011
-
-$4900.00(-5.8%)
-$22.30 K(+0.5%)
Dec 2010
-
-$5200.00(+13.0%)
-$22.20 K(+4.2%)
Sep 2010
-
-$4600.00(-39.5%)
-$21.30 K(+27.5%)
Jun 2010
-
-$7600.00(+58.3%)
-$16.70 K(+83.5%)
Jun 2010
-$20.50 K
-
-
Mar 2010
-
-$4800.00(+11.6%)
-$9100.00(+111.6%)
Dec 2009
-
-$4300.00
-$4300.00

FAQ

  • What is ADMA Biologics annual net profit?
  • What is the all time high annual net income for ADMA Biologics?
  • What is ADMA Biologics annual net income year-on-year change?
  • What is ADMA Biologics quarterly net profit?
  • What is the all time high quarterly net income for ADMA Biologics?
  • What is ADMA Biologics quarterly net income year-on-year change?
  • What is ADMA Biologics TTM net profit?
  • What is the all time high TTM net income for ADMA Biologics?
  • What is ADMA Biologics TTM net income year-on-year change?

What is ADMA Biologics annual net profit?

The current annual net income of ADMA is -$28.24 M

What is the all time high annual net income for ADMA Biologics?

ADMA Biologics all-time high annual net profit is -$20.50 K

What is ADMA Biologics annual net income year-on-year change?

Over the past year, ADMA annual net profit has changed by +$37.66 M (+57.15%)

What is ADMA Biologics quarterly net profit?

The current quarterly net income of ADMA is $35.91 M

What is the all time high quarterly net income for ADMA Biologics?

ADMA Biologics all-time high quarterly net profit is $35.91 M

What is ADMA Biologics quarterly net income year-on-year change?

Over the past year, ADMA quarterly net profit has changed by $0.00 (0.00%)

What is ADMA Biologics TTM net profit?

The current TTM net income of ADMA is $68.13 M

What is the all time high TTM net income for ADMA Biologics?

ADMA Biologics all-time high TTM net profit is $68.13 M

What is ADMA Biologics TTM net income year-on-year change?

Over the past year, ADMA TTM net profit has changed by $0.00 (0.00%)